QuidelOrtho Corp
QDEL- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001906324
No open-market purchases or sales by QuidelOrtho Corp insiders were filed in the last 90 days; 245 institutions reported holding it in 13F filings for Q2 2026, worth $1.45B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +10 vs. previous quarter
- 245
- 13F valueReported value at the end of Q2 2026
- $1.45B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding QDEL, Q2 2026
No superinvestor reported holding QDEL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by QuidelOrtho Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 13 | 6 days | Busky Joseph MChief Financial Officer | PPurchase | +3.37K | $23.66 | +$79.7K | +48.7%10.3K after | Amended |
| Feb 13, 2026 (view filing) | Feb 13 | Same day | Blaser Brian JPresident and CEO | PPurchase | +10.5K | $23.59 | +$248.6K | +35.7%40.1K after | |
| Feb 13, 2026 (view filing) | Feb 13 | Same day | Strobeck MatthewDirector | PPurchase | +10.0K | $23.96 | +$239.6K | +56.3%27.8K after | |
| Dec 10, 2025 (view filing) | Dec 10 | Same day | Rhoads Ann DDirector | PPurchase | +750 | $28.28 | +$21.2K | +5.3%15.0K after | |
| Dec 1, 2025 (view filing) | Nov 26 | 5 days | Wilkins Joseph D Jr.Director | PPurchase | +370 | $27.96 | +$10.3K | +3.2%11.9K after | |
| Nov 25, 2025 (view filing) | Nov 24 | 1 day | Busky Joseph MChief Financial Officer | PPurchase | +4.77K | $26.06 | +$124.3K | +221.9%6.92K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Widder Kenneth JDirector | SSale | −4.03K | $27.81 | −$112.0K | −9.8%37.1K after | |
| Nov 24, 2025 (view filing) | Nov 21 | 3 days | Polan Mary Lake PH DDirector | PPurchase | +1.00K | $22.43 | +$22.4K | +8.6%12.6K after | |
| Nov 20, 2025 (view filing) | Nov 19 | 1 day | Blaser Brian JPresident and CEO | PPurchase | +23.5K | $21.34 | +$501.5K | +389.5%29.5K after | |
| Dec 13, 2024 (view filing) | Dec 11 | 2 days | Blaser Brian JPresident and CEO | PPurchase | +6.03K | $41.42 | +$249.9K | New position6.03K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in QuidelOrtho Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11,202,523 | $196.2M | 0.00% | +753,396+7.2% | Added |
| FMR LLC | 7,363,696 | $129.0M | 0.01% | +772,544+11.7% | Added |
| Newtyn Management, LLC | 6,625,000 | $116.0M | 14.49% | +2,066,528+45.3% | Added |
| Vanguard Portfolio Management LLC | 4,135,464 | $72.4M | 0.00% | +103,696+2.6% | Added |
| Neuberger Berman Group LLC | 3,534,619 | $62.1M | 0.04% | +2,004,205+131.0% | Added |
| Invesco Ltd. | 3,473,432 | $60.8M | 0.00% | +355,963+11.4% | Added |
| American Century Companies Inc | 3,307,079 | $57.9M | 0.03% | +450,947+15.8% | Added |
| Rubric Capital Management LP | 3,306,281 | $57.9M | 0.53% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 3,070,054 | $53.8M | 0.00% | +17,344+0.6% | Added |
| State Street Corp | 2,978,639 | $52.2M | 0.00% | +192,018+6.9% | Added |